Clinical reference
Respiratory · Anticholinergic bronchodilator (quaternary ammonium atropine derivative) · Neonatology, Pediatrics, Pulmonology
Ipratropium bromide is an anticholinergic bronchodilator for COPD and adjunctive treatment of acute bronchospasm. In neonates: inhaled every 6–8 h via MDI (2–4 puffs, 34–68 mcg) with spacer in ventilator circuit or nebulizer (75–175 mcg). Use CFC-free (Atrovent HFA). Not useful in bronchiolitis. Avoid eye contact. Peak 1–2 h, duration 4–6 h.